DCP
ELV icon

D1 Capital Partners’s Elevance Health ELV Stock Holding History

D1 Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-326,411
Closed -$127M – 43
2025
Q2 		$127M Sell
326,411
-252,000
-44% -$101M 1.76% 24
2025
Q1 		$252M Sell
578,411
-220,589
-28% -$88.6M 3.85% 7
2024
Q4 		$295M Buy
+799,000
New +$334M 4.9% 5
2024
Q3 		– Sell
-295,932
Closed -$160M – 35
2024
Q2 		$160M Sell
295,932
-233,700
-44% -$124M 2.7% 14
2024
Q1 		$275M Sell
529,632
-159,400
-23% -$79.3M 4.18% 7
2023
Q4 		$325M Sell
689,032
-270,000
-28% -$125M 5.71% 5
2023
Q3 		$418M Buy
959,032
+268,300
+39% +$122M 6.01% 4
2023
Q2 		$307M Buy
690,732
+7,732
+1% +$3.57M 5.9% 3
2023
Q1 		$314M Buy
+683,000
New +$325M 5.91% 2

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

D1 Capital Partners's ELV Position: Q3 2025 in Review

D1 Capital Partners sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 326,411 shares — an estimated $127M sold.

D1 Capital Partners first reported a position in ELV in Q1 2023 and held it in 9 quarters. The position peaked at $418M in Q3 2023. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • D1 Capital Partners reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • D1 Capital Partners sold 326,411 Elevance Health shares in Q3 2025, an estimated $127M.
  • D1 Capital Partners first reported a position in Elevance Health in Q1 2023 and held it in 9 quarters.
  • D1 Capital Partners's Elevance Health position peaked at $418M in Q3 2023.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on D1 Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.